Navigation Links
Fujifilm to Begin Clinical Trials of 3D Mammography in the U.S.

CHICAGO, Nov. 27, 2011 /PRNewswire/ -- A year after clinical trials began in Japan, FUJIFILM Medical Systems U.S.A., Inc. today announced at the Radiological Society of North America (RSNA) 2011 Annual Meeting that clinical trials for their 3D Digital Mammography(1) technology are about to commence in the United States. The medical imaging and informatics company is currently installing 3D mammography systems at renowned medical centers across the country with plans to begin trials as early as December 2011.

"When it comes to the early detection of breast cancer, radiologists will benefit from powerful 3D technology to elevate their diagnostic confidence using an average glandular dose that is equivalent to 2D Full Field Digital Mammography (FFDM), increase their workflow, and give their patients improved outcomes," explains David Hotchkiss, Director of Modality Solutions Marketing at Fujifilm. "After thorough evaluation of needs of the patients and clinicians, we believe that, when approved by the FDA, Fujifilm's 3D Digital Mammography has the potential to become the standard of care. We remain committed to improving our breast screening technologies, and we are confident that this will be the screening technology of choice."

Currently commercially available for sale and in use in Europe, Fujifilm's 3D Digital Mammography is an innovative breast screening technology that presents the images to radiologists in an in-depth, three-dimensional view.  Pairs of stereo images of the breast are acquired and then viewed by combining a 3D review workstation and dedicated glasses specifically designed to present 3D breast images.  Because 3D Digital Mammography uses the similar clinical workflow as traditional FFDM, and because it presents the stereo images in a standard mammographic view of the breast (i.e., LCC, RCC, LMLO, or RMLO) that is familiar for radiologists, it has the potential to increase throughput and diagnostic confidence. The new 3D system will be especially powerful when viewing overlapping tissue, especially in dense breasts, and will enable radiologists to better visualize abnormalities. This assertion is supported by a previous study of 3D stereo digital mammography at Emory University(2) that demonstrated a 23 percent increase in sensitivity, and a 46 percent reduction in patient call backs.(3)

According to Satoshi Arakawa, Vice President of the Medical Systems Division at Fujifilm Europe, "European clinicians are expressing increased enthusiastic interest in the 3D system. Initial reports of ongoing studies in Germany indicate that the low-dose 3D FFDM system has yielded statistically significant reduction in recall rates." Arakawa continues, "These results are very encouraging. We hope to see many more clinics and patients benefit from this new 3D technology."

The global leader in digital mammography with more than 8,500 users throughout the world, Fujifilm is building upon its proven technological foundation for breast screening with its 3D Digital Mammography.  Images will be acquired with the AspireHD Plus(4) FFDM system upgraded with 3D capability(1) that will combine the use of innovative Direct Optical Switching (DOS) detector technology and Fujifilm's legacy 50-micron resolution to produce the exceptional image quality and detailed visualization that is particularly critical for interpreting mammography studies. This 50-micron resolution is the foundation for Fujifilm's entire breast imaging portfolio including its recently FDA cleared Aspire™ HD and CR-based FFDM.  Fujifilm is the first manufacturer to provide an FDA-approved CR-based FFDM system in the U.S., the scalable Aspire™ ClearView.

For more information or to see a demonstration of the product, please visit booth # 4009 at the RSNA2011, November 27th­– December 2nd at McCormick Place in Chicago, Ill. 

RSNA Booth # 4009, SOUTH BLG, HALL A

About Fujifilm

FUJIFILM Medical Systems U.S.A., Inc. is a leading provider of diagnostic imaging products and medical informatics solutions to meet the needs of healthcare facilities today and well into the future. From an unrivaled selection of digital x-ray systems, to the Synapse® brand of PACS, RIS and cardiovascular products, to advanced women's health imaging systems, Fujifilm has products that are ideal for any size imaging environment. FUJINON is a subsidiary of FUJIFILM Medical Systems U.S.A., Inc., and supplies technologically advanced endoscopes to the medical market. FUJIFILM Medical Systems U.S.A., Inc. is headquartered in Stamford, CT. For more information visit

(1) 3D Digital Mammography is a works-in-progress and is not yet commercially available for sale in the U.S.

(2) Stereoscopic Digital Mammography, 2007. C.J. D'Orsi, M.D., R.M. Pickett, Ph.D., M.S.Newell, M.D.,K.R. Gundry, M.D., S.F.Roberson, M.D., S.R.Bates, M.D. et al 

(3) Getty 2008 - Stereoscopic digital mammography - Improved accuracy of lesion detection in breast cancer screening" in IWDM 2008, LNCS 5116, pp. 74–79, 2008

(4) The Aspire™ HD Plus is known as Amulet f  in other countries. It requires FDA clearance and is not yet commercially available for sale in the U.S.

© 2011 FUJIFILM Medical Systems U.S.A., Inc.

SOURCE FUJIFILM Medical Systems U.S.A., Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Fujifilm Expands FDR D-EVO™ Wireless Product Line With New 17x17 Inch Detector
2. Fujifilms Aspire HD Receives FDA Clearance
3. Fujifilm Launches Ultrasound Product Line in U.S.
4. FUJIFILMs FDR D-EVO™ Wireless Now Available in the U.S.
5. Fujifilm Highlights Synapse® 3D at ACC
6. Fujifilms Exclusive Software Advances Cardiovascular Reporting Capabilities
7. Fujifilms Synapse® Mobility Extends Imaging Reach
8. FUJIFILM Revitalizes Images of Health Breast Cancer Awareness Initiative
9. FUJIFILMs FDR D-EVO™ is Now Available and Shipping
10. Fujitani Takes the Helm at FUJIFILM Medical Systems U.S.A.
11. Now Approved: Fujifilms FDR AcSelerate Direct Digital DR System
Post Your Comments:
(Date:6/23/2016)... , June 23, 2016 Any dentist who ... challenges of the current process. Many of them do not ... the technical difficulties and high laboratory costs involved. And those ... offer it at such a high cost that the majority ... Dr. Parsa Zadeh , founder of Dental ...
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
(Date:6/23/2016)... , June 23, 2016 Research ... Pharma News Issue 52" report to their offering. ... in influenza treatment creates a favourable commercial environment for MedImmune ... growing patient base that will serve to drive considerable growth ... vaccine would serve to cap sales considerably, but development is ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... ... announced its strategic partnership with Connance, a healthcare industry leader providing predictive ... proven, proprietary technology combine to provide health systems, hospitals and ambulatory surgical ...
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice ... "Film editors can give their videos a whole new perspective by using the ... of Pixel Film Studios. , ProSlice Levels contains over 30 Different presets to ...
(Date:6/25/2016)... ... 25, 2016 , ... Austin residents seeking Mohs surgery services, can now turn ... to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization ... selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a method ... —Johnson is one of the first doctors to perform the treatment. Orthobiologics are ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle Cell ... pain and the benefits of holistic treatments, Serenity Recovery Center of Marne, ... Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the red blood ...
Breaking Medicine News(10 mins):